These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants. Pipperger L; Riepler L; Kimpel J; Siller A; Stoitzner P; Bánki Z; von Laer D Oncoimmunology; 2021; 10(1):1959140. PubMed ID: 34484872 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein. Stegelmeier AA; Chan L; Mehrani Y; Petrik JJ; Wootton SK; Bridle B; Karimi K Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882969 [TBL] [Abstract][Full Text] [Related]
6. Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We? Zhang Y; Nagalo BM Front Immunol; 2022; 13():898631. PubMed ID: 35837384 [TBL] [Abstract][Full Text] [Related]
7. Oncolytic Therapy of Solid Tumors by Modified Vesicular Stomatitis Virus. Gao Y DNA Cell Biol; 2024 Feb; 43(2):57-60. PubMed ID: 38079267 [TBL] [Abstract][Full Text] [Related]
9. Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP. Vijver SV; Danklmaier S; Pipperger L; Gronauer R; Floriani G; Hackl H; Das K; Wollmann G Front Immunol; 2022; 13():1100730. PubMed ID: 36741416 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector. Wollmann G; Paglino JC; Maloney PR; Ahmadi SA; van den Pol AN Virology; 2015 Jan; 475():1-14. PubMed ID: 25462341 [TBL] [Abstract][Full Text] [Related]
11. Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus. Nikitina AS; Lipatova AV; Goncharov AO; Kliuchnikova AA; Pyatnitskiy MA; Kuznetsova KG; Hamad A; Vorobyev PO; Alekseeva ON; Mahmoud M; Shakiba Y; Anufrieva KS; Arapidi GP; Ivanov MV; Tarasova IA; Gorshkov MV; Chumakov PM; Moshkovskii SA Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563635 [TBL] [Abstract][Full Text] [Related]
12. The Propagation and Quantification of Two Emerging Oncolytic Viruses: Vesicular Stomatitis (VSV) and Zika (ZIKV). Means RE; Roy SG; Katz SG Methods Mol Biol; 2020; 2097():253-263. PubMed ID: 31776931 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus. Alkayyal AA; Ajina R; Cacciabue M; Alkayyal AA; Saeedi NH; Hussain Alshehry T; Kaboha F; Alotaibi MA; Zaidan N; Shah K; Alroqi F; Bakur Mahmoud A Front Immunol; 2023; 14():1082191. PubMed ID: 36798114 [TBL] [Abstract][Full Text] [Related]